학술논문
Hydroxyurea with Dose-Escalation to Reduce Primary Stroke Risk in Children with Sickle Cell Anemia in Tanzania: Primary Results of the Sphere Trial
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:447-448
Subject
Language
ISSN
0006-4971